UK markets open in 6 hours 13 minutes

Cyteir Therapeutics, Inc. (CYT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
17.43-0.72 (-3.97%)
At close: 4:00PM EDT
17.43 0.00 (0.00%)
After hours: 04:01PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close18.15
Open18.40
Bid16.00 x 800
Ask18.88 x 900
Day's range17.07 - 18.48
52-week range14.00 - 23.10
Volume62,807
Avg. volume138,548
Market cap616.494M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-14.90
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est31.50
  • Business Wire

    Cyteir Therapeutics Selected to Join Russell 2000® Index

    LEXINGTON, Mass., September 20, 2021--Cyteir Therapeutics, Inc. ("Cyteir") (Nasdaq: CYT), a company focused on the discovery and development of next-generation synthetically lethal therapies for cancer was added as a member of the U.S. small-cap Russell 2000® Index, effective after the US market opens on September 20, as part of the 2021 Russell indexes reconstitution. Membership in the Russell 2000® Index, which remains in place for one year, is based on membership in the broad-market Russell 3

  • Simply Wall St.

    We're Hopeful That Cyteir Therapeutics (NASDAQ:CYT) Will Use Its Cash Wisely

    We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

  • Business Wire

    Cyteir Therapeutics to Participate in the 19th Annual Morgan Stanley Global Healthcare Conference

    LEXINGTON, Mass., September 01, 2021--Cyteir Therapeutics, Inc. ("Cyteir") (Nasdaq: CYT), a company focused on the discovery and development of next-generation synthetically lethal therapies for cancer, announced that its President and Chief Executive Officer Markus Renschler, MD will participate in a fireside chat at the 19th Annual Morgan Stanley Global Healthcare Conference, being held virtually on September 10, 2021, at 11:45am ET.